• $7.2M
    Market Cap
  • -55.83%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
451,000
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
314,000
-29.91%
448,000
N/A
N/A
N/A
N/A
N/A
Gross Profit
-314,000
-10,566.67%
3,000
N/A
0
N/A
0
N/A
Sales and Marketing Expense
456,000
-6.37%
487,000
-33.65%
734,000
N/A
N/A
N/A
Research and Development Expense
-28,000
-71.43%
-98,000
+216.13%
-31,000
+3.33%
-30,000
0.00%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
1.4M
-9.62%
1.6M
+116.62%
734,000
-13.65%
850,000
-15.08%
Operating Profit
-1.7M
-22.28%
-2.2M
+183.92%
-765,000
-13.07%
-880,000
-14.65%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
36,000
+350.00%
Interest Expense
-7,000
-75.00%
-28,000
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
-7,000
-75.00%
-28,000
N/A
0
-100.00%
36,000
+350.00%
Total Nonoperating Income and Expense
7,000
-75.00%
28,000
N/A
N/A
N/A
N/A
N/A
Income before Taxes
-7.0M
+578.58%
-1.0M
-42.37%
-1.8M
+32.20%
-1.3M
-409.89%
Income Taxes
N/A
N/A
-130,000
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-7.0M
+578.58%
-1.0M
-42.37%
-1.8M
+32.20%
-1.3M
-409.89%
Net Income from Continuing Operations Applicable to Common
-7.0M
+578.58%
-1.0M
-42.37%
-1.8M
+32.20%
-1.3M
-409.89%
Basic EPS and Net Income
-0.008
+300.00%
-0.002
-33.33%
-0.003
+50.00%
-0.002
-300.00%
Diluted EPS and Net Income
-0.008
+166.67%
-0.003
0.00%
-0.003
+50.00%
-0.002
N/A
Basic Weighted Average Shares
896.2M
+33.15%
673.0M
+23.52%
544.9M
0.00%
544.9M
+2.43%
Diluted Weighted Average Shares
896.2M
+33.15%
673.0M
+23.52%
544.9M
0.00%
544.9M
+2.43%
Balance Sheet
Cash and Cash Equivalents
76,000
-79.51%
371,000
-73.52%
1.4M
-33.09%
2.1M
-29.47%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
1.6M
-48.48%
Cash and Cash Equivalents and Short-Term Investments
76,000
-79.51%
371,000
-73.52%
1.4M
-62.35%
3.7M
-39.27%
Total Current Assets
166,000
-87.61%
1.3M
-34.51%
2.0M
-46.24%
3.8M
-38.98%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
187,000
0.00%
187,000
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
201,000
-97.21%
7.2M
+1,797.37%
380,000
0.00%
380,000
-0.26%
Total Assets
166,000
-98.06%
8.6M
+252.43%
2.4M
-42.04%
4.2M
-36.75%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
138,000
0.00%
138,000
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
N/A
N/A
2.2M
N/A
N/A
N/A
N/A
N/A
Total Long-Term Debt
N/A
N/A
132,000
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
934,000
+2.86%
908,000
N/A
N/A
N/A
N/A
N/A
Total Liabilities
1.9M
-68.04%
5.8M
N/A
N/A
N/A
N/A
N/A
Retained Earnings
-165.6M
+4.17%
-159.0M
+0.48%
-158.2M
+1.14%
-156.5M
+0.86%
Total Stockholders Equity
-254,000
-104.67%
5.4M
+144.82%
2.2M
-44.49%
4.0M
-25.01%
Total Shares Outstanding
100
-100.00%
881.4M
+61.75%
544.9M
0.00%
544.9M
0.00%
Cash Flow
Cash from Operating Activities
-1.0M
-36.65%
-1.6M
+128.85%
-707,000
-21.53%
-901,000
-14.11%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
522,000
+161.85%
-844,000
-2,158.54%
41,000
+13.89%
36,000
+350.00%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
208,000
-85.63%
1.4M
N/A
N/A
N/A
385,000
0.00%
Financials Ratio
Gross Margin
N/A
N/A
0.67%
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
-481.60%
N/A
N/A
N/A
N/A
N/A
Return on Assets
-159.91%
+754.53%
-18.71%
-65.28%
-53.90%
+116.01%
-24.95%
-476.34%
Return on Equity
-269.02%
+902.61%
-26.83%
-53.18%
-57.31%
+98.37%
-28.89%
-397.03%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
N/A
N/A
0.61
N/A
N/A
N/A
N/A
N/A
Cash Ratio
N/A
N/A
0.17
N/A
N/A
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
0.05
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
0.03
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow